Post by ROTOP Pharmaka GmbH

𝗠𝗼𝗿𝗲 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗰𝗮𝗽𝗮𝗰𝗶𝘁𝘆 𝗳𝗼𝗿 𝗿𝗲𝗮𝗱𝘆 𝘁𝗼 𝘂𝘀𝗲 𝗿𝗮𝗱𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀. The new CMO Center adds specialized manufacturing capacity where it is needed most: in sterile radiopharmaceutical production. Once fully operational, the center is designed for up to approximately 𝟳𝟬,𝟬𝟬𝟬 𝘀𝘁𝗲𝗿𝗶𝗹𝗲 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗱𝗼𝘀𝗲𝘀 per year. That means more flexibility for hospitals, clinics and CDMO partners. More capacity for short lived products. And a stronger infrastructure for nuclear medicine in Germany. The center brings together GMP compliant manufacturing, radiation protection expertise, quality control and logistics in one highly specialized setup. It will also create around 𝟲𝟬 𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗷𝗼𝗯𝘀 at the site and strengthen regional expertise in a field that continues to grow in importance. More manufacturing capacity is not just a number. It means greater reliability for hospitals, clinics and CDMO partners and supports patient care where timing, quality and availability matter. #ROTOP #Radiopharmaceuticals #NuclearMedicine #RadioligandTherapy #CDMO #GMPManufacturing #MadeInGermany